Literature DB >> 15149689

Long chain amines and long chain ammonium salts as novel inhibitors of dynamin GTPase activity.

Timothy A Hill1, Luke R Odell, Annie Quan, Ruben Abagyan, Gemma Ferguson, Phillip J Robinson, Adam McCluskey.   

Abstract

We examined a number of ligands with the view of inhibiting the GTPase activity of dynamin. Dynamin contains a pleckstrin homology (PH) domain that interacts with lipids. We report a series of simple lipid-like molecules that display moderate inhibitory activity. Inhibitory activity is linked to chain length and quaternarization of the terminal amine. A change in the counterion, Cl versus Br or I, had little effect on potency. However, introduction of a hydrophobic collar proximal to the charged site was beneficial to dynamin GTPase inhibitory action. The most potent compound was myristoyl trimethyl ammonium bromide (MTMAB, IC(50) 3.15 microM).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149689     DOI: 10.1016/j.bmcl.2004.03.096

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  18 in total

1.  Analysis of synaptic vesicle endocytosis in synaptosomes by high-content screening.

Authors:  James A Daniel; Chandra S Malladi; Emma Kettle; Adam McCluskey; Phillip J Robinson
Journal:  Nat Protoc       Date:  2012-07-05       Impact factor: 13.491

2.  Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism.

Authors:  Callista B Harper; Sally Martin; Tam H Nguyen; Shari J Daniels; Nickolas A Lavidis; Michel R Popoff; Gordana Hadzic; Anna Mariana; Ngoc Chau; Adam McCluskey; Phillip J Robinson; Frederic A Meunier
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

3.  Dynasore disrupts trafficking of herpes simplex virus proteins.

Authors:  Mascha B Mues; Natalia Cheshenko; Duncan W Wilson; Leslie Gunther-Cummins; Betsy C Herold
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

4.  Synthesis of Dynole 34-2, Dynole 2-24 and Dyngo 4a for investigating dynamin GTPase.

Authors:  Mark J Robertson; Fiona M Deane; Phillip J Robinson; Adam McCluskey
Journal:  Nat Protoc       Date:  2014-03-20       Impact factor: 13.491

5.  The Rhodadyns, a New Class of Small Molecule Inhibitors of Dynamin GTPase Activity.

Authors:  Mark J Robertson; Gordana Hadzic; Joseph Ambrus; D Yuri Pomè; Emily Hyde; Ainslie Whiting; Anna Mariana; Lisa von Kleist; Ngoc Chau; Volker Haucke; Phillip J Robinson; Adam McCluskey
Journal:  ACS Med Chem Lett       Date:  2012-03-26       Impact factor: 4.345

6.  Dynamin impacts homology-directed repair and breast cancer response to chemotherapy.

Authors:  Sophia B Chernikova; Rochelle B Nguyen; Jessica T Truong; Stephano S Mello; Jason H Stafford; Michael P Hay; Andrew Olson; David E Solow-Cordero; Douglas J Wood; Solomon Henry; Rie von Eyben; Lei Deng; Melanie Hayden Gephart; Asaithamby Aroumougame; Claudia Wiese; John C Game; Balázs Győrffy; J Martin Brown
Journal:  J Clin Invest       Date:  2018-10-29       Impact factor: 14.808

7.  Dynamin inhibitors induce caspase-mediated apoptosis following cytokinesis failure in human cancer cells and this is blocked by Bcl-2 overexpression.

Authors:  Sanket Joshi; Antony W Braithwaite; Phillip J Robinson; Megan Chircop
Journal:  Mol Cancer       Date:  2011-06-28       Impact factor: 27.401

8.  Increased expression of the large GTPase dynamin 2 potentiates metastatic migration and invasion of pancreatic ductal carcinoma.

Authors:  R D Eppinga; E W Krueger; S G Weller; L Zhang; H Cao; M A McNiven
Journal:  Oncogene       Date:  2011-08-15       Impact factor: 9.867

9.  High Cytotoxic Activity of Phosphonium Salts and Their Complementary Selectivity towards HeLa and K562 Cancer Cells: Identification of Tri-n-butyl-n-hexadecylphosphonium bromide as a Highly Potent Anti-HeLa Phosphonium Salt.

Authors:  Barbara Bachowska; Julia Kazmierczak-Baranska; Marcin Cieslak; Barbara Nawrot; Dorota Szczęsna; Joanna Skalik; Piotr Bałczewski
Journal:  ChemistryOpen       Date:  2012-02-17       Impact factor: 2.911

Review 10.  A review of Dynamin 2 involvement in cancers highlights a promising therapeutic target.

Authors:  Delphine Trochet; Marc Bitoun
Journal:  J Exp Clin Cancer Res       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.